Table 5.
Disease model | Treatment | Duration | Mechanisms of action | References |
---|---|---|---|---|
Type 2 diabetic rats | 10% xylitol solution (Ad libitum) | 4 weeks |
|
[58] |
Non-diabetic and type 2 diabetic rats | 164.31–2628.99 mM xylitol in vitro. 657.25–2628.99 mM xylitol ex vivo. Xylitol (1 g/kg bw) |
2 h Single oral dose |
|
[59] |
Non-obese healthy men | 25 g of xylitol | Single oral dose |
|
[65] |
Non-diabetic human subjects | 25 or 50 g of sorbitol | Single oral dose |
|
[70] |
No-diabetic and type 2 diabetic rats | 2.5–20% sorbitol ex vivo. Sorbitol (0.4 g/kg bw) |
2 h Single oral dose |
|
[73] |
Non-diabetic rats | Diet containing 20% mannitol | 8 weeks |
|
[74] |
Non-diabetic human subjects | 50 g of maltitol | Single oral dose |
|
[77] |
Non-diabetic and type 2 diabetic human subjects | 30 or 50 g of maltitol |
|
[78] | |
Non-obese healthy men | 25 g of lactitol | Single oral dose |
|
[65] |
Non-diabetic healthy human subjects | 30 g of isomalt (Daily) | 4 weeks |
|
[44] |
Non-diabetic and type 2 diabetic rats | 2.5–20% erythritol ex vivo. Erythritol (1 g/kg bw) |
2 h Single oral dose |
|
[85] |
Type 2 diabetic rats | 100, 200 or 400 mg of erythritol (Daily) | 10 days |
|
[92] |